Dysgammaglobulinemia: Clinical Trials

32 trials for Dysgammaglobulinemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 6 unknown, 3 recruiting, 2 active not recruiting. 8 Phase 3, 7 Phase 2, 4 Phase 1, 3 Not applicable, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 38Completed 7, Unknown 1
Phase 27Completed 5, Active not recruiting 1, Recruiting 1
Phase 14Completed 4
Not applicable3Active not recruiting 1, Completed 1, Terminated 1
Phase 43Completed 3

Follow Dysgammaglobulinemia: new trials by email Literature Review of Dysgammaglobulinemia trials Research Report on Dysgammaglobulinemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)
Hematopoietic stem cell transplant (HSCT) - Common Variable Immunodeficiency (CVID), Primary Immune Regulatory Disorder
Phase 2RecruitingPaul Szabolcs252026-05-042026-05-15
A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders
AMPD3, OMIM*102772, AMP Deaminase Deficiency, AK1, OMIM *103000, Adenylate Kinase Deficiency
RecruitingNational Human Genome Research Institute (NHGRI)9992023-12-192026-08-19
Bronchiectasis Prevalence in Patients With Primary Humoral Immunodefiency in Champagne-Ardenne Region, France
Blood test, chest CT scan - Primary Immunodeficiency, Common Variable Immunodeficiency
Not applicableCompletedCHU de Reims462022-11-282025-12-18
Epidemiology of IgA Selective Deficiency - Clinical Manifestations and Risk of Transmission
COVID-19
UnknownUniversity Hospital, Strasbourg, France1202022-04-092023-12-19
Immune Response Following COVID-19 Vaccination
Rapid antibody test - IgM and IgG in Blood
UnknownTexas Cardiac Arrhythmia Research Foundation5002021-01-152021-02-03
Pro-inflammatory Role of Blood Platelets in Critically Ill Patients With Septic Shock.
Septic shock, Systemic Inflammatory Response Syndrome - Septic Shock
CompletedUniversity Hospital, Bordeaux2022020-11-092024-04-26
Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
data collection - Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes
RecruitingPaul Szabolcs502020-08-202026-01-13
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
CDX-1140, CDX-301, pembrolizumab - Melanoma, Non-small Cell Lung Cancer
Phase 1CompletedCelldex Therapeutics1322017-12-012024-03-28
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Subgam - Primary Immune Deficiency Disorders, Common Variable Immunodeficiency
Phase 3CompletedBio Products Laboratory382015-08-202018-09-12
Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous
Treatment by clopidogrel - Systemic Lupus Erythematous
Phase 1 / Phase 2CompletedUniversity Hospital, Bordeaux182015-08-192026-05-14
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Gammaplex (5%), Gammaplex 10 - Primary Immune Deficiency Disorders, Common Variable Immunodeficiency
Phase 3CompletedBio Products Laboratory482014-02-012017-03-29
Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)
Hematopoietic Stem Cell Transplant - Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection
Phase 2CompletedMedical College of Wisconsin472013-12-012022-12-08
IVIG Treatment for Asthmatic Patients With IgG Subclass Deficiency
Immune Globulin - Asthma
Phase 3UnknownAjou University School of Medicine302013-12-012016-05-02
PNEUMOCELL - Conjugated Pneumococcal Vaccination in Patients With Immunoglobulin G-deficiency
Prevenar13 - IgG Deficiency
Phase 2CompletedKarolinska University Hospital202013-05-012014-06-16
Immune Disorder HSCT Protocol
Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan - Immune Deficiency Disorders, Severe Combined Immunodeficiency
Phase 2Active not recruitingWashington University School of Medicine202013-04-292026-02-19
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
Alemtuzumab 0.3 mg, Cyclophosphamide, Busulfan - SCID, Omenn's Syndrome
Not applicableActive not recruitingMasonic Cancer Center, University of Minnesota572012-09-042026-06-17
300 Antibody Diagnostic Test Kit
Acute Bacterial Infections, Acute Viral Infections
UnknownThe Plasma Source3002012-08-012012-07-20
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
Gammaplex - Primary Immune Deficiency Disorders, Common Variable Immunodeficiency
Phase 4CompletedBio Products Laboratory252011-03-012014-12-23
Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells
Hematopoietic stem cell transplantation - Sickle Cell Disease, Thalassemia
Phase 1 / Phase 2CompletedChildren's Hospital Los Angeles252008-08-012016-06-23
Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects
Flebogamma 5% DIF - Primary Immune Deficiency Disease
Phase 4CompletedInstituto Grifols, S.A.242008-05-012017-02-02

Showing 20 of 32. Sign in to see all of them.

Narrower conditions

Hyper-IgM Immunodeficiency Syndrome (18)  ·  Common Variable Immunodeficiency (14)  ·  Primary Immunodeficiency Diseases (10)  ·  Wiskott-Aldrich Syndrome (10)  ·  Bruton type agammaglobulinemia (8)  ·  IgG Deficiency (8)  ·  Granulomatous Disease, Chronic (7)  ·  Immunologic Deficiency Syndromes (6)  ·  Chediak-Higashi Syndrome (5)  ·  Lymphohistiocytosis, Hemophagocytic (5)  ·  Severe Combined Immunodeficiency (5)  ·  Agammaglobulinemia (4)  ·  Hyper-IgM Immunodeficiency Syndrome, Type 1 (4)  ·  Lymphoproliferative Disorders (4)  ·  Genetic Diseases, Inborn (3)

Broader conditions

Blood Protein Disorders (32)  ·  Hemic and Lymphatic Diseases (32)  ·  Hematologic Diseases (31)  ·  Immune System Diseases (29)  ·  Immunologic Deficiency Syndromes (26)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (23)  ·  Genetic Diseases, Inborn (20)  ·  Genetic Diseases, X-Linked (15)  ·  Primary Immunodeficiency Diseases (13)  ·  Leukocyte Disorders (12)  ·  Lymphatic Diseases (12)  ·  Blood Coagulation Disorders (10)  ·  Blood Coagulation Disorders, Inherited (10)  ·  Cytopenia (10)

Interventions

Immunoglobulins, Intravenous (5)  ·  gamma-Globulins (5)  ·  Stem Cell Transplantation (3)  ·  Busulfan (2)  ·  Cyclophosphamide (2)  ·  Melphalan (2)  ·  13-valent pneumococcal vaccine (1)  ·  Alemtuzumab (1)  ·  Anti-Bacterial Agents (1)  ·  Antilymphocyte Serum (1)  ·  B-Cell Activating Factor (1)  ·  Cyclosporine (1)  ·  Data Collection (1)  ·  Drug Therapy (1)  ·  Etoposide (1)

Sponsors

Bio Products Laboratory (4)  ·  CSL Behring (3)  ·  National Human Genome Research Institute (NHGRI) (2)  ·  Paul Szabolcs (2)  ·  University Hospital, Bordeaux (2)  ·  Ajou University School of Medicine (1)  ·  CHU de Reims (1)  ·  Celldex Therapeutics (1)  ·  Children's Hospital Los Angeles (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  FFF Enterprises (1)  ·  Fairview University Medical Center (1)  ·  Instituto Grifols, S.A. (1)  ·  Karolinska University Hospital (1)  ·  Masonic Cancer Center, University of Minnesota (1)

Countries

United States (23)  ·  France (4)  ·  Canada (2)  ·  Chile (1)  ·  Hungary (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Eric Wolford (2)  ·  Paul Szabolcs, MD (2)  ·  Akhilesh Chouksey, MD (1)  ·  Andrea Natale (1)  ·  Ashish K Jain, M.D. (1)  ·  Chaim Roifman, MD (1)  ·  Daniel Suez, MD (1)  ·  Don McNeil, MD (1)  ·  E AM Sanders, PhD, MD (1)  ·  Elizabeth K Garabedian, R.N. (1)  ·  Eyal Grunebaum, MD (1)  ·  Gordan L Sussman, MD (1)  ·  Hans D. Ochs (1)  ·  Hisham Abdel-Azim, MD (1)

Results publications

PMID 36818468, PMID 17479360, PMID 18814020, PMID 19218820, PMID 20217199, PMID 21725047, PMID 28410816, PMID 29635077, PMID 31599480, PMID 33152483, PMID 37042921, PMID 39271296, PMID 39919133, PMID 41773292

NIH funding

2014 (1), U10HL069294 (1), U24CA076518 (1)